BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 38577613)

  • 1. Gasdermin E benefits CD8
    Luo B; Zhang S; Yu X; Tan D; Wang Y; Wang M
    Biomark Res; 2024 Jun; 12(1):59. PubMed ID: 38853246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity.
    Zhang JN; Dong MM; Cao W; Chen HG; Gu HY; Feng YL; Zhang EF; He JS; Liu SC; Xie AY; Cai Z
    Br J Cancer; 2024 Jun; ():. PubMed ID: 38877108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway.
    Shen J; Guillén Mancina E; Chen S; Manolakou T; Gad H; Warpman Berglund U; Sanjiv K; Helleday T
    Oncogenesis; 2024 May; 13(1):17. PubMed ID: 38796460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer cell proliferation" [Cancer Lett. 586 (2024) 216707/CAN_216707].
    Liu X; Zheng W; Zhang L; Cao Z; Cong X; Hu Q; Hou J; Jin X; Yuan Q; Lin L; Tan J; Lu J; Zhang Y; Zhang N
    Cancer Lett; 2024 Jul; 595():217003. PubMed ID: 38839536
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling.
    Shen R; Liu D; Wang X; Guo Z; Sun H; Song Y; Wang D
    Front Cell Dev Biol; 2021; 9():828657. PubMed ID: 35265630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung Cancer.
    Zhu G; Liu J; Li Y; Huang H; Chen C; Wu D; Cao P; Su L; Wang Y; Zhang H; Liu H; Chen J
    J Cancer; 2024; 15(9):2601-2612. PubMed ID: 38577613
    [No Abstract]   [Full Text] [Related]  

  • 7. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
    Shi Y; Shin DS
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.
    Sun D; Tian L; Zhu Y; Wo Y; Liu Q; Liu S; Li H; Hou H
    Mol Med; 2020 Aug; 26(1):78. PubMed ID: 32791957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
    Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
    Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
    Alessi JV; Ricciuti B; Spurr LF; Gupta H; Li YY; Glass C; Nishino M; Cherniack AD; Lindsay J; Sharma B; Felt KD; Rodig SJ; Cheng ML; Sholl LM; Awad MM
    J Thorac Oncol; 2021 Jul; 16(7):1176-1187. PubMed ID: 33845210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
    Wu T; Hu E; Xu S; Chen M; Guo P; Dai Z; Feng T; Zhou L; Tang W; Zhan L; Fu X; Liu S; Bo X; Yu G
    Innovation (Camb); 2021 Aug; 2(3):100141. PubMed ID: 34557778
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Zhang H; Liu M; Pan Z; Liu H; Chen J
    Front Immunol; 2021; 12():670040. PubMed ID: 34512623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.